| UniProt ID | NRBF2_HUMAN | |
|---|---|---|
| UniProt AC | Q96F24 | |
| Protein Name | Nuclear receptor-binding factor 2 | |
| Gene Name | NRBF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 287 | |
| Subcellular Localization | Nucleus . Cytoplasm . Cytoplasmic vesicle . Cytoplasmic vesicle, autophagosome . | |
| Protein Description | May modulate transcriptional activation by target nuclear receptors. Can act as transcriptional activator (in vitro).; Involved in starvation-induced autophagy probably by its association with PI3K complex I (PI3KC3-C1). However, effects has been described variably. Involved in the induction of starvation-induced autophagy. [PubMed: 24785657 Stabilzes PI3KC3-C1 assembly and enhances ATG14-linked lipid kinase activity of PIK3C3 (By similarity Proposed to negatively regulate basal and starvation-induced autophagy and to inhibit PIK3C3 activity by modulating interactions in PI3KC3-C1] | |
| Protein Sequence | MEVMEGPLNLAHQQSRRADRLLAAGKYEEAISCHKKAAAYLSEAMKLTQSEQAHLSLELQRDSHMKQLLLIQERWKRAQREERLKAQQNTDKDAAAHLQTSHKPSAEDAEGQSPLSQKYSPSTEKCLPEIQGIFDRDPDTLLYLLQQKSEPAEPCIGSKAPKDDKTIIEEQATKIADLKRHVEFLVAENERLRKENKQLKAEKARLLKGPIEKELDVDADFVETSELWSLPPHAETATASSTWQKFAANTGKAKDIPIPNLPPLDFPSPELPLMELSEDILKGFMNN | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 85 | Acetylation | AQREERLKAQQNTDK HHHHHHHHHHHHCCH | 50.82 | 7663087 | |
| 90 | Phosphorylation | RLKAQQNTDKDAAAH HHHHHHHCCHHHHHH | 39.84 | 23927012 | |
| 100 | Phosphorylation | DAAAHLQTSHKPSAE HHHHHHHHCCCCCHH | 38.88 | 23927012 | |
| 101 | Phosphorylation | AAAHLQTSHKPSAED HHHHHHHCCCCCHHH | 19.29 | 23927012 | |
| 103 | Acetylation | AHLQTSHKPSAEDAE HHHHHCCCCCHHHCC | 40.20 | 7663095 | |
| 105 | Phosphorylation | LQTSHKPSAEDAEGQ HHHCCCCCHHHCCCC | 49.44 | 23927012 | |
| 108 | Ubiquitination | SHKPSAEDAEGQSPL CCCCCHHHCCCCCCC | 50.03 | 29967540 | |
| 113 | Phosphorylation | AEDAEGQSPLSQKYS HHHCCCCCCCHHCCC | 38.37 | 29255136 | |
| 116 | Phosphorylation | AEGQSPLSQKYSPST CCCCCCCHHCCCCCH | 28.19 | 29255136 | |
| 118 | Ubiquitination | GQSPLSQKYSPSTEK CCCCCHHCCCCCHHH | 44.30 | 29967540 | |
| 119 | Phosphorylation | QSPLSQKYSPSTEKC CCCCHHCCCCCHHHH | 20.41 | 23898821 | |
| 120 | Phosphorylation | SPLSQKYSPSTEKCL CCCHHCCCCCHHHHH | 21.29 | 25159151 | |
| 122 | Phosphorylation | LSQKYSPSTEKCLPE CHHCCCCCHHHHHHH | 43.17 | 27794612 | |
| 123 | Phosphorylation | SQKYSPSTEKCLPEI HHCCCCCHHHHHHHH | 42.73 | 27794612 | |
| 138 | Ubiquitination | QGIFDRDPDTLLYLL CCCCCCCHHHHHHHH | 37.06 | 29967540 | |
| 143 | Phosphorylation | RDPDTLLYLLQQKSE CCHHHHHHHHHCCCC | 14.42 | 28674151 | |
| 148 | Ubiquitination | LLYLLQQKSEPAEPC HHHHHHCCCCCCCCC | 43.77 | 29967540 | |
| 149 | Phosphorylation | LYLLQQKSEPAEPCI HHHHHCCCCCCCCCC | 44.46 | 27251275 | |
| 156 | Ubiquitination | SEPAEPCIGSKAPKD CCCCCCCCCCCCCCC | 11.61 | 24816145 | |
| 190 | Ubiquitination | EFLVAENERLRKENK HHHHHHHHHHHHHHH | 44.60 | 24816145 | |
| 200 | Ubiquitination | RKENKQLKAEKARLL HHHHHHHHHHHHHHH | 52.59 | 24816145 | |
| 250 | Phosphorylation | WQKFAANTGKAKDIP HHHHHHHCCCCCCCC | 35.02 | 29396449 | |
| 268 | Phosphorylation | LPPLDFPSPELPLME CCCCCCCCCCCCHHH | 30.88 | 25159151 | |
| 277 | Phosphorylation | ELPLMELSEDILKGF CCCHHHCCHHHHHHH | 21.66 | 27732954 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NRBF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NRBF2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PPARA_HUMAN | PPARA | physical | 10786636 | |
| RXRA_HUMAN | RXRA | physical | 10786636 | |
| THB_HUMAN | THRB | physical | 10786636 | |
| CPVL_HUMAN | CPVL | physical | 20562859 | |
| PA2G4_HUMAN | PA2G4 | physical | 20562859 | |
| PGK1_HUMAN | PGK1 | physical | 20562859 | |
| CA216_HUMAN | C1orf216 | physical | 25416956 | |
| PI3R4_HUMAN | PIK3R4 | physical | 26186194 | |
| PK3C3_HUMAN | PIK3C3 | physical | 26186194 | |
| CACO2_HUMAN | CALCOCO2 | physical | 26186194 | |
| TGFA1_HUMAN | TGFBRAP1 | physical | 26186194 | |
| BECN1_HUMAN | BECN1 | physical | 26186194 | |
| GALT_HUMAN | GALT | physical | 26186194 | |
| BAKOR_HUMAN | ATG14 | physical | 26186194 | |
| SOGA3_HUMAN | SOGA3 | physical | 26186194 | |
| BAKOR_HUMAN | ATG14 | physical | 28514442 | |
| PK3C3_HUMAN | PIK3C3 | physical | 28514442 | |
| BECN1_HUMAN | BECN1 | physical | 28514442 | |
| GALT_HUMAN | GALT | physical | 28514442 | |
| SOGA3_HUMAN | SOGA3 | physical | 28514442 | |
| PI3R4_HUMAN | PIK3R4 | physical | 28514442 | |
| TGFA1_HUMAN | TGFBRAP1 | physical | 28514442 | |
| NRBF2_HUMAN | NRBF2 | physical | 27630019 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-90; SER-105; SER-113;SER-268 AND SER-277, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113, AND MASSSPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-268, AND MASSSPECTROMETRY. | |
| "Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. | |